In fact, C. elegans was recently used to find an existing drug that could be repurposed effectively and had beneficial effects in treating a child with a genetic phosphomannomutase 2 deficiency (Iyer et al., 2019; Perlstein et al., 2021). This evidence concerns the gene PMM2 and hyperinsulinemic hypoglycemia, familial, 4.